148 related articles for article (PubMed ID: 16893996)
21. Nuclear translocation of IFN-gamma is an intrinsic requirement for its biologic activity and can be driven by a heterologous nuclear localization sequence.
Subramaniam PS; Green MM; Larkin J; Torres BA; Johnson HM
J Interferon Cytokine Res; 2001 Nov; 21(11):951-9. PubMed ID: 11747627
[TBL] [Abstract][Full Text] [Related]
22. Cloning and expression of the VP1 major capsid protein of diabetogenic encephalomyocarditis (EMC) virus and prevention of EMC virus-induced diabetes by immunization with the recombinant VP1 protein.
Jun HS; Yoon SW; Kang Y; Pak CY; Lee MC; Yoon JW
J Gen Virol; 1995 Oct; 76 ( Pt 10)():2557-66. PubMed ID: 7595359
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of an experimental oil-adjuvanted encephalomyocarditis vaccine in elephants, mice and pigs.
Hunter P; Swanepoel SP; Esterhuysen JJ; Raath JP; Bengis RG; van der Lugt JJ
Vaccine; 1998 Jan; 16(1):55-61. PubMed ID: 9607009
[TBL] [Abstract][Full Text] [Related]
24. Stable antiviral expression in BALB/c 3T3 cells carrying a beta interferon sequence behind a major histocompatibility complex promoter fragment.
Seif I; De Maeyer E; Riviere I; De Maeyer-Guignard J
J Virol; 1991 Feb; 65(2):664-71. PubMed ID: 1846190
[TBL] [Abstract][Full Text] [Related]
25. Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice.
Werner GH; Jasmin C; Chermann JC
J Gen Virol; 1976 Apr; 31(1):59-64. PubMed ID: 177729
[TBL] [Abstract][Full Text] [Related]
26. Differing attachment of diabetogenic and nondiabetogenic variants of encephalomyocarditis virus to beta-cells.
Kaptur PE; Thomas DC; Giron DJ
Diabetes; 1989 Sep; 38(9):1103-8. PubMed ID: 2475377
[TBL] [Abstract][Full Text] [Related]
27. Role of invariant NKT cells in lipopolysaccharide-induced lethal shock during encephalomyocarditis virus infection.
Ando T; Ito H; Ohtaki H; Kanbe A; Hirata A; Hara A; Seishima M
Immunobiology; 2017 Feb; 222(2):350-357. PubMed ID: 27665995
[TBL] [Abstract][Full Text] [Related]
28. Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection.
Rodriguez M; Zoecklein LJ; Howe CL; Pavelko KD; Gamez JD; Nakane S; Papke LM
J Virol; 2003 Nov; 77(22):12252-65. PubMed ID: 14581562
[TBL] [Abstract][Full Text] [Related]
29. The carboxyl terminus of interferon-gamma contains a functional polybasic nuclear localization sequence.
Subramaniam PS; Mujtaba MG; Paddy MR; Johnson HM
J Biol Chem; 1999 Jan; 274(1):403-7. PubMed ID: 9867857
[TBL] [Abstract][Full Text] [Related]
30. Antiviral action of trehalose dimycolate against EMC virus: role of macrophages and interferon alpha/beta.
Guillemard E; Geniteau-Legendre M; Mabboux B; Poilane I; Kergot R; Lemaire G; Petit JF; Labarre C; Quero AM
Antiviral Res; 1993 Oct; 22(2-3):201-13. PubMed ID: 7506511
[TBL] [Abstract][Full Text] [Related]
31. Involvement of the IRF-1 transcription factor in antiviral responses to interferons.
Kimura T; Nakayama K; Penninger J; Kitagawa M; Harada H; Matsuyama T; Tanaka N; Kamijo R; Vilcek J; Mak TW
Science; 1994 Jun; 264(5167):1921-4. PubMed ID: 8009222
[TBL] [Abstract][Full Text] [Related]
32. Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.
Kawamoto S; Oritani K; Asada H; Takahashi I; Ishikawa J; Yoshida H; Yamada M; Ishida N; Ujiie H; Masaie H; Tomiyama Y; Matsuzawa Y
J Virol; 2003 Sep; 77(17):9622-31. PubMed ID: 12915574
[TBL] [Abstract][Full Text] [Related]
33. Synergistic antiviral effect of a combination of mouse interferon-alpha and interferon-gamma on mouse hepatitis virus.
Fuchizaki U; Kaneko S; Nakamoto Y; Sugiyama Y; Imagawa K; Kikuchi M; Kobayashi K
J Med Virol; 2003 Feb; 69(2):188-94. PubMed ID: 12683406
[TBL] [Abstract][Full Text] [Related]
34. Expression of intracellular interferon constitutively activates ISGF3 and confers resistance to EMC viral infection.
Rutherford MN; Kumar A; Coulombe B; Skup D; Carver DH; Williams BR
J Interferon Cytokine Res; 1996 Jul; 16(7):507-10. PubMed ID: 8836915
[TBL] [Abstract][Full Text] [Related]
35. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.
Ilyinskii PO; Wang R; Balk SP; Exley MA
J Virol; 2006 Jul; 80(14):7146-58. PubMed ID: 16809320
[TBL] [Abstract][Full Text] [Related]
36. Synergistic effects of tacrolimus and human interferon-alpha A/D in murine viral myocarditis.
Kanda T; Nagaoka H; Kaneko K; Wilson JE; McManus BM; Imai S; Suzuki T; Murata K; Kobayashi I
J Pharmacol Exp Ther; 1995 Jul; 274(1):487-93. PubMed ID: 7542339
[TBL] [Abstract][Full Text] [Related]
37. TRIM13 is a negative regulator of MDA5-mediated type I interferon production.
Narayan K; Waggoner L; Pham ST; Hendricks GL; Waggoner SN; Conlon J; Wang JP; Fitzgerald KA; Kang J
J Virol; 2014 Sep; 88(18):10748-57. PubMed ID: 25008915
[TBL] [Abstract][Full Text] [Related]
38. Staphylococcal Enterotoxin Superantigens Induce Prophylactic Antiviral Activity Against Encephalomyocarditis Virus
Mujtaba MG; Johnson HM; Parrish JM
Viral Immunol; 2021; 34(6):392-400. PubMed ID: 33566741
[TBL] [Abstract][Full Text] [Related]
39. Effects of free immunoglobulin light chains on viral myocarditis.
Matsumori A; Shimada M; Jie X; Higuchi H; Groot Kormelink T; Redegeld FA
Circ Res; 2010 May; 106(9):1533-40. PubMed ID: 20360247
[TBL] [Abstract][Full Text] [Related]
40. MOV10 Provides Antiviral Activity against RNA Viruses by Enhancing RIG-I-MAVS-Independent IFN Induction.
Cuevas RA; Ghosh A; Wallerath C; Hornung V; Coyne CB; Sarkar SN
J Immunol; 2016 May; 196(9):3877-86. PubMed ID: 27016603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
